- INOUE A, Ichikawa T, Wada D, Maruyama S, et al
M49L and other drug resistance mutations emerging in individuals after administration of ensitrelvir in Japanese clinical settings.
Antiviral Res. 2025;236:106118.
PubMed Abstract available - ZIAN D, Iaconis D, Nenci S, Crusco A, et al
The Efficiency of High-Throughput Screening (HTS) and in-silico data analysis during medical emergencies: identification of effective antiviral 3CLpro inhibitors.
Antiviral Res. 2025 Feb 18:106119. doi: 10.1016/j.antiviral.2025.106119.
PubMed Abstract available - LUETKEMEYER AF, Chew KW, Lacey S, Hughes MD, et al
Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial.
Clin Infect Dis. 2025 Feb 17:ciaf029. doi: 10.1093.
PubMed Abstract available - SIM BZ, Wolfe CR
Antiviral Trials-Navigating the Shifting Sands of a Pandemic.
Clin Infect Dis. 2025 Feb 17:ciaf031. doi: 10.1093.
PubMed - FERREIRA FC, Pervin T, Tang WW, Hediger JA, et al
Respiratory Shedding of Infectious SARS-CoV-2 Omicron XBB.1.41.1 Lineage among Captive White-Tailed Deer, Texas, USA.
Emerg Infect Dis. 2025;31:267-274.
PubMed Abstract available - DAVIES MA, de Gier B, Guy RL, Coelho J, et al
Streptococcus pyogenes emm Type 3.93 Emergence, the Netherlands and England.
Emerg Infect Dis. 2025;31:229-236.
PubMed Abstract available - SUN M, Wu M, Zhang L, Zhou H, et al
Clinical characteristics of optic neuritis following COVID-19 during Omicron outbreak in China.
Graefes Arch Clin Exp Ophthalmol. 2025 Feb 21. doi: 10.1007/s00417-025-06780.
PubMed Abstract available - OLMOS M, Fuentes N, Busico M, Gallardo A, et al
Effectiveness of bundle of care on tolerance of awake-prone positioning in patients with acute respiratory failure. A multicenter observational study.
Intensive Care Med. 2025 Feb 17. doi: 10.1007/s00134-025-07804.
PubMed Abstract available - AO G, Li T, Wang Y, Balzer N, et al
The effect of amubarvimab-romlusevimab on clinical outcomes in patients with COVID-19: A meta-analysis.
J Infect. 2025;90:106442.
PubMed - MAZARAKIS N, Toh ZQ, Neal E, Bright K, et al
The immunogenicity, reactogenicity, and safety of a bivalent mRNA or protein COVID-19 vaccine given as a fourth dose.
J Infect. 2025 Feb 18:106447. doi: 10.1016/j.jinf.2025.106447.
PubMed Abstract available - ZHANG Y, Chen H, Li Y, Luo C, et al
Animal Models for Long COVID: Current Advances, Limitations, and Future Directions.
J Med Virol. 2025;97:e70237.
PubMed Abstract available - LI Y, Lu J, He L, Jiang C, et al
Repeated Omicron Infections Overcome T Cell Immune Imprinting to Original SARS-CoV-2.
J Med Virol. 2025;97:e70264.
PubMed Abstract available - FRAENKEL CJ, Thuresson S, Medstrand P, Alsved M, et al
Comparison of Airborne SARS-CoV-2 Omicron and Pre-Delta Variants Around Infected Patients.
J Med Virol. 2025;97:e70258.
PubMed Abstract available - KIM J, Han E, Kim J, Kim YJ, et al
Comparative Evaluation of the PowerChek Respiratory Virus Panel RT-PCR Assay Detecting 16 Respiratory Viruses Including SARS-CoV-2.
J Med Virol. 2025;97:e70243.
PubMed Abstract available - ZHAO Y, He C, Peng M, Li M, et al
Large-Scale Screening of CD4(+) T-Cell Epitopes From SARS-CoV-2 Proteins and the Universal Detection of SARS-CoV-2 Specific T Cells for Northeast Asian Population.
J Med Virol. 2025;97:e70241.
PubMed Abstract available - HO SY, Zhou YT, Ho SY, Hu YL, et al
Clinical Characteristics and Severity Predictors of Pediatric Adenovirus Infections.
J Med Virol. 2025;97:e70248.
PubMed Abstract available - HOTA M, Wondeu ALD, Abakar MF, Dezoumbe K, et al
Integrated Seroprevalence and Genome-Based Study of SARS-CoV-2 Viral Strains in N'Djamena: Insights Into Chad's COVID-19 Epicenter.
J Med Virol. 2025;97:e70234.
PubMed Abstract available - DAMODAR T, Pattabiraman C, Singh B, Jose M, et al
Microbiological Investigations for Chikungunya Virus in Children With Acute Encephalitis Syndrome in a Non-Outbreak Setting in Southern India.
J Med Virol. 2025;97:e70233.
PubMed Abstract available - SOULTSIOTI M, de Jong AWM, Blomberg N, Tas A, et al
Perturbation of de novo lipogenesis hinders MERS-CoV assembly and release, but not the biogenesis of viral replication organelles.
J Virol. 2025 Feb 20:e0228224. doi: 10.1128/jvi.02282.
PubMed Abstract available - KRAMMER F, Barclay WS, Beer M, Brown IH, et al
Europe needs a sustainably funded influenza research and response network.
Lancet Infect Dis. 2025 Feb 17:S1473-3099(25)00068.
PubMed - BROWN JR, Seymour JF, Jurczak W, Aw A, et al
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia.
N Engl J Med. 2025;392:748-762.
PubMed Abstract available - MARR LC
Researchers overlooked airborne diseases for centuries - then COVID-19 changed everything.
Nature. 2025;638:607-608.
PubMed
Learn COVID pandemic lessons - before it's too late.
Nature. 2025 Feb 18. doi: 10.1038/d41586-025-00498.
PubMed- MALLAPATY S
What sparked the COVID pandemic? Mounting evidence points to raccoon dogs.
Nature. 2025 Feb 21. doi: 10.1038/d41586-025-00426.
PubMed - NARAYAN AK, Foster N, Kadom N, Scott JA, et al
Six Steps to Improving Health Equity Using Quality Improvement and Patient Safety Tools.
Radiology. 2025;314:e232750.
PubMed Abstract available - ZASLAVSKY ME, Craig E, Michuda JK, Sehgal N, et al
Disease diagnostics using machine learning of B cell and T cell receptor sequences.
Science. 2025;387:eadp2407.
PubMed Abstract available - FLOREZ L, Echeverri-De la Hoz D, Calderon A, Serrano-Coll H, et al
Preclinical evaluation of the RBD-Trimeric vaccine: A novel approach to strengthening biotechnological sovereignty in developing countries against SARS-CoV-2 variants.
Travel Med Infect Dis. 2025;64:102820.
PubMed Abstract available
Antiviral Res
No comments:
Post a Comment